Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Czekalla, J; Beasley, CM; Dellva, MA; Berg, PH; Grundy, S
   Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis
   JOURNAL OF CLINICAL PSYCHIATRY
   
   J. Czekalla et al., "Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis", J CLIN PSY, 62(3), 2001, pp. 191-198
2. Czekalla, J; Kollack-Walker, S; Beasley, CM
   Cardiac safety parameters of olanzapine: Comparison with other atypical and typical antipsychotics
   JOURNAL OF CLINICAL PSYCHIATRY
   
   J. Czekalla et al., "Cardiac safety parameters of olanzapine: Comparison with other atypical and typical antipsychotics", J CLIN PSY, 62, 2001, pp. 35-40
3. Hubl, D; Kleinlogel, H; Frohlich, L; Weinandi, T; Maurer, K; Holstein, W; Czekalla, J; Dierks, T
   Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine
   PSYCHOPHARMACOLOGY
   
   D. Hubl et al., "Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine", PSYCHOPHAR, 158(3), 2001, pp. 281-288
4. Braus, DF; Schmitt, A; Czekalla, J; Severa, L
   Therapy-resistant psychotic-depressive disorder - Remission with a selective serotonin reuptake inhibitor in combination with olanzapine
   CLINICAL DRUG INVESTIGATION
   
   D.F. Braus et al., "Therapy-resistant psychotic-depressive disorder - Remission with a selective serotonin reuptake inhibitor in combination with olanzapine", CLIN DRUG I, 20(6), 2000, pp. 455-459
5. Dittmann, RW; Czekalla, J; Hundemer, HP; Linden, M
   Efficacy and safety findings from naturalistic fluoxetine drug treatment in adolescent and young adult patients
   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
   
   R.W. Dittmann et al., "Efficacy and safety findings from naturalistic fluoxetine drug treatment in adolescent and young adult patients", J CH AD PSY, 10(2), 2000, pp. 91-102
6. Volz, HP; Riehemann, S; Maurer, I; Smesny, S; Sommer, M; Rzanny, R; Holstein, W; Czekalla, J; Sauer, H
   Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: A P-31 chemical shift spectroscopic-imaging study
   BIOLOGICAL PSYCHIATRY
   
   H.P. Volz et al., "Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: A P-31 chemical shift spectroscopic-imaging study", BIOL PSYCHI, 47(11), 2000, pp. 954-961
7. CZEKALLA J; GASTPAR M; HUBNER WD; JAGER D
   THE EFFECT OF HYPERICUM EXTRACT ON CARDIAC CONDUCTION AS SEEN IN THE ELECTROCARDIOGRAM COMPARED TO THAT OF IMIPRAMINE
   Pharmacopsychiatry
   
   J. Czekalla et al., "THE EFFECT OF HYPERICUM EXTRACT ON CARDIAC CONDUCTION AS SEEN IN THE ELECTROCARDIOGRAM COMPARED TO THAT OF IMIPRAMINE", Pharmacopsychiatry, 30, 1997, pp. 86-88